U.S. market Closed. Opens in 6 hours

EYPT | EyePoint Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
Revenue46.02M41.40M36.94M34.44M20.36M2.96M7.54M1.62M26.57M3.47M2.14M3.53M4.96M23.05M12.16M3.48M2.23M1.47M629.52K265.23K74.35K516.32K
Cost of Revenue4.63M8.33M8.18M5.82M2.69MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit41.39M33.08M28.76M28.61M17.68M2.96MN/AN/A26.57M3.47M2.14M3.53M4.96M23.05M12.16M3.48M2.23M1.47M629.52K265.23KN/AN/A
Operating Expenses115.05M112.02M84.04M65.90M65.54M29.23M26.11M23.39M20.14M17.04M14.17M13.91M14.97M13.96M16.80M28.38M37.78M29.14M10.88M6.50MN/AN/A
Selling, General & Admin50.69M60.32M53.08M46.02M47.71M13.06M11.23M9.01M8.06M7.47M7.17M6.87M8.10M6.97M8.79M13.95M12.98M15.88M3.81M1.60M565.51KN/A
Research & Development64.36M49.64M28.50M17.42M15.37M16.18M14.88M14.38M12.09M9.57M7.00M7.04M6.86M6.99M8.01M14.43M20.03M11.70M6.29M4.87M3.08M1.80M
Other Operating Expenses-63.46M2.05M2.46M2.46M2.46M14.84MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.76M1.56M781.71K27.35KN/AN/A
Operating Income-73.66M-78.94M-55.28M-37.29M-47.86M-26.27M-18.58M-21.77M6.42M-13.57M-12.03M-10.38M-10.00M9.09M-4.64M-24.90M-35.54M-27.68M-10.25M-6.24M-3.60M-1.28M
Other Expenses / Income2.95M-23.32M-3.14M-8.10M-8.93M-26.28M91.00K72.00K22.00K83.00K14.00K-14.62M1.16M-315.00K1.17M-51.25M-91.66M-305.43K-1.23M1.01M-807.00-972.68K
Before Tax Income-70.71M-102.25M-58.42M-45.39M-56.79M-53.17M-18.48M-21.70M6.44M-13.48M-12.02M-25.00M-8.85M8.78M-3.46M-76.15M-127.20M-27.98M-11.49M-5.22M-3.60M-2.25M
Income Tax Expenses83.00K22.26M5.50M7.26M6.18M-25.56MN/A-155.00K96.00K-130.00K-117.00K-169.00K-218.00K23.00K-951.00K-483.00K-23.53M-7.07MN/AN/AN/AN/A
Net Income-70.80M-124.51M-63.91M-52.65M-62.97M-53.17M-18.48M-21.55M6.35M-13.36M-11.90M-24.84M-8.63M8.75M-2.51M-75.67M-103.67M-20.91M-11.18M-2.56M-1.86M-2.25M
Interest Expenses1.25M3.19M5.50M7.26M6.18M720.00KN/AN/AN/A1.00K2.00KN/AN/AN/AN/A507.00K1.94M3.37MN/A3.92KN/AN/A
Basic Shares Outstanding38.90M37.32M28.76M12.84M10.43M4.62M3.53M3.16M2.94M2.74M2.30M2.08M1.95M1.84M1.83M1.82M44.80M9.99K5.24M3.06M2.54M4.11M
Diluted Shares Outstanding38.90M37.32M28.76M12.84M10.43M4.62M3.53M3.16M3.06M2.74M2.30M2.08M1.95M1.89M1.83M1.82M44.80M9.99K20.76M12.28M2.54M4.11M
EBITDA-73.20M-74.76M-52.52M-34.77M-44.35M-26.17M-17.67M-20.79M7.33M-12.57M-11.02M-22.78M-5.49M12.10M-24.00K-75.25M-116.55M-15.91M-9.94M-2.31M-1.65M-2.25M
EBITDA Margin-159.06%-180.56%-142.19%-100.97%-217.76%-883.92%-234.38%-1,283.58%27.57%-361.85%-514.28%-645.97%-110.59%52.50%-0.20%-2,164.82%-5,214.54%-1,085.59%-1,579.21%-872.68%-2,213.21%-436.07%
EBIT-69.47M-99.06M-52.92M-38.14M-50.62M-78.01M-18.48M-21.70M6.44M-13.48M-12.02M-25.00M-8.85M8.78M-3.46M-75.65M-125.26M-24.61M-11.18M-2.56M-1.86M-2.25M
EBIT Margin-150.95%-239.26%-143.26%-110.74%-248.55%-2,634.55%-245.19%-1,339.63%24.25%-388.25%-560.66%-709.13%-178.17%38.07%-28.47%-2,176.24%-5,604.61%-1,679.23%-1,776.47%-963.52%-2,498.46%-436.07%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙